Aprea Therapeutics, Inc. ($APRE)
Filing Information
| Accession Number | 0001104659-26-075278 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 17, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
15,690
Total Value
$0.00
P&L
+inf% (+$12,235.06)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 16, 2026 | Grant/Award | 3,135 | $0.00 | $0.00 | 48,910 | Direct | โ | View Details | |
Director | Stock Options (Right to Buy) | Derivative | Jun 16, 2026 | Grant/Award | 12,555 | $0.00 | $0.00 | 12,555 | Direct | โ | View Details |